{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:57:59Z","timestamp":1783112279794,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intraperitoneal (IP) aerosolized anticancer drug delivery was recently introduced in the treatment of patients with peritoneal metastases. However, little is known on the effect of treatment parameters on the spatial distribution of the aerosol droplets in the peritoneal cavity. Here, computational fluid dynamics (CFD) modeling was used in conjunction with experimental validation in order to investigate the effect of droplet size, liquid flow rate and viscosity, and the addition of an electrostatic field on the homogeneity of IP aerosol. We found that spatial distribution is optimal with small droplet sizes (1\u20135\u00a0\u00b5m). Using the current clinically used technology (droplet size of 30\u00a0\u00b5m), the optimal spatial distribution of aerosol is obtained with a liquid flow rate of 0.6\u00a0mL\u00a0s<jats:sup>\u22121<\/jats:sup>. Compared to saline, nebulization of higher viscosity liquids results in less homogeneous aerosol distribution. The addition of electrostatic precipitation significantly improves homogeneity of aerosol distribution, but no further improvement is obtained with voltages higher than 6.5\u00a0kV. The results of the current study will allow to choose treatment parameters and settings in order to optimize spatial distribution of IP aerosolized drug, with a potential to enhance its anticancer effect.<\/jats:p>","DOI":"10.1038\/s41598-022-10369-8","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T15:02:42Z","timestamp":1650034962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling"],"prefix":"10.1038","volume":"12","author":[{"given":"Mohammad","family":"Rahimi-Gorji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Debbaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghader","family":"Ghorbaniasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Willaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"10369_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi, B. et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88, 358\u2013363 (2000).","journal-title":"Cancer"},{"key":"10369_CR2","first-page":"283","volume":"65","author":"LA Lambert","year":"2015","unstructured":"Lambert, L. A. Looking up: Recent advances in understanding and treating peritoneal carcinomatosis. CA 65, 283\u2013298 (2015).","journal-title":"CA"},{"key":"10369_CR3","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini, F. et al. Peritoneal carcinomatosis. World J. Gastroenterol. 19, 6979 (2013).","journal-title":"World J. Gastroenterol."},{"key":"10369_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ejso.2010.09.006","volume":"36","author":"Y Yonemura","year":"2010","unstructured":"Yonemura, Y. et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur. J. Surg. Oncol. 36, 1131\u20131138 (2010).","journal-title":"Eur. J. Surg. Oncol."},{"key":"10369_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen, W. P. & Flessner, M. F. Intraperitoneal therapy for peritoneal tumors: Biophysics and clinical evidence. Nat. Rev. Clin. Oncol. 7, 108\u2013115 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10369_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/14656566.2014.879571","volume":"15","author":"Y Yonemura","year":"2014","unstructured":"Yonemura, Y. et al. Peritoneal cancer treatment. Expert Opin. Pharmacother. 15, 623\u2013636 (2014).","journal-title":"Expert Opin. Pharmacother."},{"key":"10369_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jso.22017","volume":"104","author":"RS Gill","year":"2011","unstructured":"Gill, R. S. et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity. J. Surg. Oncol. 104, 692\u2013698 (2011).","journal-title":"J. Surg. Oncol."},{"key":"10369_CR8","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df, W., Hetzel, A., Nadiradze, G., Sagynaliev, E. & Reymond, M. A. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg. Endosc. 26, 1849\u20131855 (2012).","journal-title":"Surg. Endosc."},{"key":"10369_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass, W. et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: Proof of concept. Surg. Endosc. 26, 847\u2013852 (2012).","journal-title":"Surg. Endosc."},{"key":"10369_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","volume":"12","author":"G Nadiradze","year":"2020","unstructured":"Nadiradze, G. et al. Overcoming drug resistance by taking advantage of physical principles: Pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers 12, 34 (2020).","journal-title":"Cancers"},{"key":"10369_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler, D. et al. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg. Endosc. 31, 1778\u20131784 (2017).","journal-title":"Surg. Endosc."},{"key":"10369_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/pp-2017-0006","volume":"2","author":"D Schnelle","year":"2017","unstructured":"Schnelle, D., Weinreich, F.-J., Kibat, J. & Reymond, M. A. A new ex vivo model for optimizing distribution of therapeutic aerosols: The (inverted) bovine urinary bladder. Pleura Peritoneum 2, 37\u201341 (2017).","journal-title":"Pleura Peritoneum"},{"key":"10369_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer, C. B. et al. Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: Preliminary clinical experience. Gynecol. Oncol. 132, 307\u2013311 (2014).","journal-title":"Gynecol. Oncol."},{"key":"10369_CR14","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2018-0112","author":"L Van De Sande","year":"2018","unstructured":"Van De Sande, L. et al. Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane\u2122) for peritoneal carcinomatosis\u2013a phase I first-in-human study. Pleura Peritoneum https:\/\/doi.org\/10.1515\/pp-2018-0112 (2018).","journal-title":"Pleura Peritoneum"},{"key":"10369_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","volume":"32","author":"A Bellendorf","year":"2018","unstructured":"Bellendorf, A. et al. Scintigraphic peritoneography reveals a non-uniform 99m Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model. Surg. Endosc. 32, 166\u2013174 (2018).","journal-title":"Surg. Endosc."},{"key":"10369_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.addr.2020.09.007","volume":"170","author":"F Huang","year":"2021","unstructured":"Huang, F. et al. Role of CFD based in silico modelling in establishing an in vitro-in vivo correlation of aerosol deposition in the respiratory tract. Adv. Drug Deliv. Rev. 170, 369\u2013385. https:\/\/doi.org\/10.1016\/j.addr.2020.09.007 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10369_CR17","doi-asserted-by":"publisher","first-page":"2000655","DOI":"10.1002\/adhm.202000655","volume":"9","author":"L Van de Sande","year":"2020","unstructured":"Van de Sande, L. et al. Electrostatic intraperitoneal aerosol delivery of nanoparticles: Proof of concept and preclinical validation. Adv. Healthc. Mater. 9, 2000655 (2020).","journal-title":"Adv. Healthc. Mater."},{"key":"10369_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/cjce.5450630202","volume":"63","author":"K Varde","year":"1985","unstructured":"Varde, K. Spray cone angle and its correlation in a high pressure fuel spray. Can. J. Chem. Eng. 63, 183\u2013187 (1985).","journal-title":"Can. J. Chem. Eng."},{"key":"10369_CR19","unstructured":"European Pharmacopoeia, E. 27 (2019)."},{"key":"10369_CR20","unstructured":"Meshing: User\u2019s Guide, COMSOL Multiphysics. https:\/\/www.comsol.com\/blogs\/how-to-inspect-your-mesh-in-comsol-multiphysics\/ (2020)."},{"key":"10369_CR21","unstructured":"Wilcox, D. (Inc, 2002)."},{"key":"10369_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5658-5","volume":"19","author":"L Van de Sande","year":"2019","unstructured":"Van de Sande, L. et al. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC). BMC Cancer 19, 1\u201310 (2019).","journal-title":"BMC Cancer"},{"key":"10369_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/02786820802549441","volume":"43","author":"J Yao","year":"2009","unstructured":"Yao, J., Zhao, Y., Hu, G., Fan, J. & Cen, K. Numerical simulation of particle dispersion in the wake of a circular cylinder. Aerosol Sci. Technol. 43, 174\u2013187 (2009).","journal-title":"Aerosol Sci. Technol."},{"key":"10369_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00936835","volume":"52","author":"S Elghobashi","year":"1994","unstructured":"Elghobashi, S. On predicting particle-laden turbulent flows. Appl. Sci. Res. 52, 309\u2013329 (1994).","journal-title":"Appl. Sci. Res."},{"key":"10369_CR25","doi-asserted-by":"publisher","DOI":"10.1201\/9781420040470","volume-title":"Multiphase Flow Handbook","author":"CT Crowe","year":"2005","unstructured":"Crowe, C. T. Multiphase Flow Handbook (CRC Press, 2005)."},{"key":"10369_CR26","volume-title":"Computational Technique for Mutiphase Flow","author":"HY Guan","year":"2010","unstructured":"Guan, H. Y. Computational Technique for Mutiphase Flow (Butterworth-Heinemann, 2010)."},{"key":"10369_CR27","unstructured":"Particle Tracing Module: User\u2019s Guide, COMSOL Multiphysics, 2020)."},{"key":"10369_CR28","volume-title":"Computational Fluid and Particle Dynamics in the Human Respiratory System","author":"J Tu","year":"2012","unstructured":"Tu, J., Inthavong, K. & Ahmadi, G. Computational Fluid and Particle Dynamics in the Human Respiratory System (Springer Science & Business Media, 2012)."},{"key":"10369_CR29","first-page":"24","volume-title":"Multiphase Flow Handbook","author":"CT Crowe","year":"2006","unstructured":"Crowe, C. T. & Michaelides, E. E. Basic concepts and definitions. In Multiphase Flow Handbook (ed. Press, C. R. C.) 24\u201325 (2006)."},{"key":"10369_CR30","doi-asserted-by":"publisher","DOI":"10.1201\/9781315120911","volume-title":"Atomization and Sprays","author":"AH Lefebvre","year":"2017","unstructured":"Lefebvre, A. H. & McDonell, V. G. Atomization and Sprays (CRC Press, 2017)."},{"key":"10369_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1018952425107","volume":"10","author":"AJ Hickey","year":"1993","unstructured":"Hickey, A. J. & Martonen, T. B. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives. Pharm. Res. 10, 1\u20137 (1993).","journal-title":"Pharm. Res."},{"key":"10369_CR32","volume-title":"Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles","author":"WC Hinds","year":"1999","unstructured":"Hinds, W. C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles (Wiley, 1999)."},{"key":"10369_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.resp.2008.07.002","volume":"163","author":"C Kleinstreuer","year":"2008","unstructured":"Kleinstreuer, C., Zhang, Z. & Li, Z. Modeling airflow and particle transport\/deposition in pulmonary airways. Respir. Physiol. Neurobiol. 163, 128\u2013138 (2008).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10369_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/027868299304165","volume":"31","author":"Y-S Cheng","year":"1999","unstructured":"Cheng, Y.-S., Zhou, Y. & Chen, B. T. Particle deposition in a cast of human oral airways. Aerosol Sci. Technol. 31, 286\u2013300 (1999).","journal-title":"Aerosol Sci. Technol."},{"key":"10369_CR35","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.ejso.2021.02.012","volume":"47","author":"HS Keck","year":"2021","unstructured":"Keck, H. S. et al. Experimental evaluation of icodextrin delivery as pressurized aerosol (PIPAC): Antiadhesive and cytotoxic effects. Eur. J. Surg. Oncol. 47, 1434\u20131440 (2021).","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10369-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:00:48Z","timestamp":1669341648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10369-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6305"}}